Related Image: DuPont and International Rice Research Institute Partner to Boost Rice Yields |
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRNe...n Africa: Everyone,s Problem and Heritage" , ...iversity, 2-3 June 2010 the,Gabonese Republic is h...Gabon) on the issue of safeguarding biological res...by government and state leaders, ministers,scient...
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewswi...er the leaders in technology development and produ... MEMS, announced the December 11th deadline for te..., Now in its 14th year, TechConnect World, in ass...itute (NSTI), and the Clean Technology and Sustain...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...n its novel oral JAK2 inhibitor, SB1518, at The Am...nd Exposition in New Orleans. ,, Data will be p...dose-escalation trial of SB1518 detailing its safe...ic (PK/PD) profile in dose levels ranging from 100...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswir... or the "Company") (NYSE: SCR ), a leading pharm... manufacturing, and marketing of branded,generic a...ounced that 105 of,its drugs have been included in..., which was issued by China,s Ministry of Human Re...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3... easy to use, and rapid alternative to blood-based... testing according to a new MUHC study. The study...est is 100 per cent accurate and patients?preferre..., a postdoctoral fellow at the McGill University H... individuals for HIV infection at the Mahatma Gand...
...rom the University of Sheffield have received join...e Research Council (EPSRC) and the Ministry of Def...ct bacteria. The new method will use a polymer whi...rs bacteria, allowing scientists to easily identif...onal methodologies. , The new technology will be...
...l climate change causes changes in the species com...ow coastal oceans. This applies also to fish popul...een global warming and declining fish stocks were ...der to estimate future changes, it is essential to...ater temperature on the biology of organisms under...
Other Biology News:Rapid oral HIV test shows great promise according to MUHC-led research 2How fish species suffer as a result of warmer waters 23' RACE Adapter Primer from Invitrogen
...ic peptide derived from the N-terminal region of t...teins. Specificity: Specific for the human occlud... Caco-2 cell lysates). Reactivity with rat mouse ...tern blotting Immunohistochemistry Immunofluoresce...
ARCA (Anti Reverse Cap Analog) from Ambion
TRIzol LS Reagent from Invitrogen
Biology Products: